期刊文献+

Liquid chromatographic methods for determination of the new antiepileptic drugs stiripentol, retigabine, rufinamide and perampanel: A comprehensive and critical review 被引量:2

下载PDF
导出
摘要 The new antiepileptic drugs perampanel,retigabine,rufinamide and stiripentol have been recently approved for different epilepsy types.Being them an innovation in the antiepileptics armamentarium,a lot of investigations regarding their pharmacological properties are yet to be performed.Besides,considering their broad anticonvulsant activities,an extension of their therapeutic indications may be worthy of investigation,especially regarding other seizure types as well as other central nervous system disorders.Although different liquid chromatographic(LC)methods coupled with ultraviolet,fluorescence,mass or tandem-mass spectrometry detection have already been developed for the determination of perampanel,retigabine,rufinamide and stiripentol,new and more cost-effective methods are yet required.Therefore,this review summarizes the main analytical aspects regarding the liquid chromatographic methods developed for the analysis of perampanel,retigabine(and its main active metabolite),rufinamide and stiripentol in biological samples and pharmaceutical dosage forms.Furthermore,the physicochemical and stability properties of the target compounds will also be addressed.Thus,this review gathers,for the first time,important background information on LC methods that have been developed and applied for the determination of perampanel,retigabine,rufinamide and stiripentol,which should be considered as a starting point if new(bio)analytical techniques are aimed to be implemented for these drugs.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2021年第4期405-421,共17页 药物分析学报(英文版)
基金 supported by Banco Santander/Totta(Portugal)through the fellowship BID/ICI-FCS/CICS/Santander UniversidadesUBI/2017 by Foundation for Science and Technology(FCT)through the fellowship SFRH/BD/136028/2018 by FEDER funds through the POCI-COMPETE 2020-Operational Program Competitiveness and Internationalization in Axis I(Project No.POCI-01-0145FEDER-007491) National Funds by FCT(Project No.UIDB/00709/2020 and Project No.UIDP/00709/2020) the support provided by FEDER funds through the“Programa Operacional do Centro”(Project No.CENTRO-010145-FEDER-000013)。
  • 相关文献

参考文献2

二级参考文献23

  • 1M J O'Neil. The Merck Index[M].Merck Research Laboratories,Whitehouse Station,NJ,2006.
  • 2M J McLean,M Schmutz,M Pozza. The influence of rufinamide on sodium currents and action potential firing in rodent neurons[abstract no 3 062][J].Epilepsia,2005,(Suppl 6):S375.
  • 3L A Brunner,M L Powell. An automated method for the determination of a new potential antiepileptic agent(CGP 33101)in human plasma using high performance liquid chromatography[J].Biomedical Chromatography,1992,(06):278-282.
  • 4M C Rouan,C Souppart,L Alif. Automated analysis of a novel anti-epileptic compound,CGP 33,101,and its metabolite,CGP 47,292,in body fluids by high-performance liquid chromatography and liquid-solid extraction[J].Journal of Chromatography B:Biomedical Sciences and Applications,1995,(02):307-313.
  • 5M C Rouan,C Buffet,L Masson. Practice of solid-phase extraction and protein precipitation in the 96-well format combined with high-performance liquid chromatography-ultraviolet detection for the analysis of drugs in plasma and brain[J].Journal of Chromatography B:Biomedical Sciences and Applications,2001,(01):45-55.
  • 6M Contin,S Mohamed,C Candela. Simultaneous HPLC-UV analysis of rufmamide,zonisamide,lamotrigine,oxcarbazepinemonohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy[J].Journal of Chromatography B:Analytical Technologies in the Biomedical and Life Sciences,2010,(3-4):461-465.
  • 7M Iolanda,R Manuela,F Cinzia. Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva[J].Analytical Biochemistry,2011,(03):1013-1021.
  • 8M Giancarlo la,M Sabrina,F Luca. Rapid assay of rufinamide in dried blood spots by a new liquid chromatographytandem mass spectrometric method[J].Journal of Pharmaceutical and Biomedical Analysis,2011,(01):192-197.
  • 9S Muneer,C Jose Gnana Babu,R Hakeem. Development and validation of RP-HPLC method for estimation of rufinamide in bulk and its pharmaceutical dosage form[J].Int J Pharm Res Anal,2012,(01):9-13.
  • 10Rundfeldt, C.; Netzer, R. Neurosci. Lett. 2000B, 282, 73-76.

共引文献3

同被引文献7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部